Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-013346-83Phase 2Completed
Phase 2 trial of pandemic A/H1N1 influenza vaccine in influenza A virus infection (H1N1) (4 arms), sponsored by Sanofi. Primary endpoints: Immunogenicity by HAI and SN testing after each vaccination and Safety. Started Jul 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-013346-83.